Bank of New York Mellon’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $791K | Buy |
175,343
+11,198
| +7% | +$50.5K | ﹤0.01% | 3230 |
|
|
2025
Q1 | $762K | Sell |
164,145
-6,167
| -4% | -$28.6K | ﹤0.01% | 3191 |
|
|
2024
Q4 | $1.18M | Buy |
170,312
+3,619
| +2% | +$25.1K | ﹤0.01% | 3034 |
|
|
2024
Q3 | $883K | Buy |
166,693
+56,829
| +52% | +$301K | ﹤0.01% | 3203 |
|
|
2024
Q2 | $411K | Buy |
109,864
+15,845
| +17% | +$59.3K | ﹤0.01% | 3677 |
|
|
2024
Q1 | $663K | Sell |
94,019
-6,497
| -6% | -$45.8K | ﹤0.01% | 3354 |
|
|
2023
Q4 | $568K | Buy |
100,516
+6,461
| +7% | +$36.5K | ﹤0.01% | 3478 |
|
|
2023
Q3 | $451K | Sell |
94,055
-35
| -0% | -$168 | ﹤0.01% | 3599 |
|
|
2023
Q2 | $645K | Buy |
94,090
+5,635
| +6% | +$38.6K | ﹤0.01% | 3449 |
|
|
2023
Q1 | $689K | Sell |
88,455
-837
| -0.9% | -$6.52K | ﹤0.01% | 3316 |
|
|
2022
Q4 | $680K | Buy |
89,292
+1,660
| +2% | +$12.6K | ﹤0.01% | 3387 |
|
|
2022
Q3 | $716K | Buy |
87,632
+17,424
| +25% | +$142K | ﹤0.01% | 3372 |
|
|
2022
Q2 | $679K | Sell |
70,208
-4,111
| -6% | -$39.8K | ﹤0.01% | 3412 |
|
|
2022
Q1 | $1.04M | Buy |
74,319
+42,340
| +132% | +$594K | ﹤0.01% | 3286 |
|
|
2021
Q4 | $653K | Buy |
31,979
+4,123
| +15% | +$84.2K | ﹤0.01% | 3631 |
|
|
2021
Q3 | $621K | Buy |
+27,856
| New | +$621K | ﹤0.01% | 3671 |
|